Westpac Banking Corp’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Buy
826
+363
+78% +$168K 0.03% 284
2026
Q1
$222K Hold
463
0.02% 351
2025
Q4
$260K Buy
+463
New +$263K 0.02% 333
2023
Q4
Sell
-2,113
Closed -$512K 488
2023
Q3
$512K Buy
+2,113
New +$540K 0.04% 298
2022
Q1
Sell
-8,253
Closed -$1.8M 840
2021
Q4
$1.8M Sell
8,253
-2,092
-20% -$438K 0.02% 590
2021
Q3
$1.96M Buy
+10,345
New +$1.89M 0.02% 593

Other funds holding MEDP

Westpac Banking Corp's MEDP Position: Q2 2026 in Review

Westpac Banking Corp increased its Medpace (MEDP) stake by 78% in Q2 2026, buying an estimated $168K and bringing the position to 826 shares worth $437K. The position accounts for 0.03% of the portfolio, ranked #284.

Westpac Banking Corp first reported a position in MEDP in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.96M in Q3 2021. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Westpac Banking Corp held 826 shares of Medpace worth $437K as of Q2 2026.
  • Westpac Banking Corp bought 363 Medpace shares in Q2 2026, an estimated $168K.
  • Medpace made up 0.03% of Westpac Banking Corp's portfolio in Q2 2026, its #284 holding.
  • Westpac Banking Corp first reported a position in Medpace in Q3 2021 and has held it in 6 quarters since.
  • Westpac Banking Corp's Medpace position peaked at $1.96M in Q3 2021.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Westpac Banking Corp's 13F filing for Q2 2026, filed 12 Aug 2026.